The document presents the EuroAsian Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension (2-2023), developed by a working group of experts from various countries in the EuroAsian region. The guidelines are based on a thorough review of scientific and medical literature, as well as the latest clinical data from multiple international studies. They aim to provide updated recommendations for the diagnosis and management of pulmonary hypertension (PH), including specific therapies and surgical treatments. Key points covered in the guidelines include: - **Clinical Symptoms and Signs**: Overview of common symptoms such as dyspnea, fatigue, and chest pain. - **Physical Examination**: Techniques and findings that aid in the diagnosis. - **Imaging and Laboratory Tests**: Detailed descriptions of various diagnostic methods, including electrocardiography, chest radiography, and echocardiography. - **Hemodynamic Assessment**: Criteria for diagnosing different types of PH, including pre-capillary and post-capillary hypertension. - **Risk Groups**: Classification of patients based on their clinical characteristics and hemodynamic data. - **Diagnosis Algorithm**: Step-by-step approach to diagnosing PH. - **Treatment**: Recommendations for pharmacological and surgical treatments, including specific therapies for different subtypes of PH. - **Special Considerations**: Additional considerations for specific patient groups, such as those with high-altitude PH, sleep apnea, and other comorbidities. The guidelines emphasize the importance of individualized treatment plans, considering the patient's specific condition and response to therapy. They also highlight the need for continuous monitoring and reassessment of treatment plans to ensure optimal outcomes.The document presents the EuroAsian Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension (2-2023), developed by a working group of experts from various countries in the EuroAsian region. The guidelines are based on a thorough review of scientific and medical literature, as well as the latest clinical data from multiple international studies. They aim to provide updated recommendations for the diagnosis and management of pulmonary hypertension (PH), including specific therapies and surgical treatments. Key points covered in the guidelines include: - **Clinical Symptoms and Signs**: Overview of common symptoms such as dyspnea, fatigue, and chest pain. - **Physical Examination**: Techniques and findings that aid in the diagnosis. - **Imaging and Laboratory Tests**: Detailed descriptions of various diagnostic methods, including electrocardiography, chest radiography, and echocardiography. - **Hemodynamic Assessment**: Criteria for diagnosing different types of PH, including pre-capillary and post-capillary hypertension. - **Risk Groups**: Classification of patients based on their clinical characteristics and hemodynamic data. - **Diagnosis Algorithm**: Step-by-step approach to diagnosing PH. - **Treatment**: Recommendations for pharmacological and surgical treatments, including specific therapies for different subtypes of PH. - **Special Considerations**: Additional considerations for specific patient groups, such as those with high-altitude PH, sleep apnea, and other comorbidities. The guidelines emphasize the importance of individualized treatment plans, considering the patient's specific condition and response to therapy. They also highlight the need for continuous monitoring and reassessment of treatment plans to ensure optimal outcomes.